Dynamic Advisor Solutions’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,000
Closed -$21.1K 940
2025
Q2
$21.1K Hold
10,000
﹤0.01% 894
2025
Q1
$12.2K Sell
10,000
-1,000
-9% -$1.4K ﹤0.01% 844
2024
Q4
$14.2K Sell
11,000
-1,000
-8% -$2.4K ﹤0.01% 648
2024
Q3
$33K Hold
12,000
﹤0.01% 919
2024
Q2
$27.1K Sell
12,000
-407
-3% -$1.24K ﹤0.01% 937
2024
Q1
$29.7K Hold
12,407
﹤0.01% 927
2023
Q4
$21.1K Hold
12,407
﹤0.01% 891
2023
Q3
$23.8K Hold
12,407
﹤0.01% 838
2023
Q2
$17.9K Hold
12,407
﹤0.01% 800
2023
Q1
$26.1K Hold
12,407
﹤0.01% 742
2022
Q4
$14K Hold
12,407
﹤0.01% 716
2022
Q3
$20K Hold
12,407
﹤0.01% 676
2022
Q2
$16K Buy
12,407
+2,407
+24% +$3.46K ﹤0.01% 696
2022
Q1
$16K Hold
10,000
﹤0.01% 719
2021
Q4
$21K Hold
10,000
﹤0.01% 713
2021
Q3
$39K Hold
10,000
﹤0.01% 729
2021
Q2
$32K Hold
10,000
﹤0.01% 718
2021
Q1
$22K Hold
10,000
﹤0.01% 658
2020
Q4
$22K Hold
10,000
﹤0.01% 653
2020
Q3
$27K Hold
10,000
﹤0.01% 585
2020
Q2
$31K Hold
10,000
﹤0.01% 531
2020
Q1
$20K Hold
10,000
﹤0.01% 472
2019
Q4
$29K Hold
10,000
﹤0.01% 551
2019
Q3
$37K Hold
10,000
0.01% 509
2019
Q2
$42K Hold
10,000
0.01% 496
2019
Q1
$51K Hold
10,000
0.01% 418
2018
Q4
$48K Hold
10,000
0.01% 389
2018
Q3
$60K Hold
10,000
0.01% 404
2018
Q2
$64K Hold
10,000
0.01% 404
2018
Q1
$47K Hold
10,000
0.01% 363
2017
Q4
$33K Hold
10,000
0.01% 248
2017
Q3
$21K Hold
10,000
0.01% 219
2017
Q2
$25K Buy
+10,000
New +$26.6K 0.01% 217

Other funds holding GALT

Dynamic Advisor Solutions's GALT Position: Q3 2025 in Review

Dynamic Advisor Solutions sold out of Galectin Therapeutics (GALT) in Q3 2025, closing a stake of 10,000 shares — an estimated $21.1K sold.

Dynamic Advisor Solutions first reported a position in GALT in Q2 2017 and held it in 33 quarters. The position peaked at $64K in Q2 2018. 84 funds tracked by Wall St. Rank hold GALT as of Q3 2025.

  • Dynamic Advisor Solutions reported no remaining Galectin Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 10,000 Galectin Therapeutics shares in Q3 2025, an estimated $21.1K.
  • Dynamic Advisor Solutions first reported a position in Galectin Therapeutics in Q2 2017 and held it in 33 quarters.
  • Dynamic Advisor Solutions's Galectin Therapeutics position peaked at $64K in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q3 2025.

Based on Dynamic Advisor Solutions's 13F filing for Q3 2025, filed 9 Oct 2025.